Diabetic nephropathy

Diabetes Care

Volumn 21, Issue SUPPL. 1, 1998, Pages

  Molitch, M E ^a   DeFronzo, R A ^a   Franz, M J ^a   Keane, W F ^a   Mogensen, C E ^a   Parving, H H ^a   Steffes, M W ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATE BINDING AGENT;

DIABETES MELLITUS; DIABETIC NEPHROPATHY; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; PROTEIN INTAKE; PROTEINURIA; REVIEW;

EID: 0031985190     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.1.s50     Document Type: Review

References (7)

1. American Diabetes Association: Standards of medical care for patients with diabetes mellitus (Position Statement). Diabetes Care 21 (Suppl. 1):S23-S31, 1998
2. American Diabetes Association: Treatment of hypertension in diabetes (Consensus Statement). Diabetes Care 16:1394-1401, 1993
3. Bennett PH, Haffner S, Kasiske BL, Keane WF, Mogensen CE, Parving H-H, Steffes MW, Striker GE: Screening and management of microalbuminuria in patients with diabetes mellitus. Am J Kidney Dis 25:107-112, 1995
4. DeFronzo RA: Diabetic nephropathy: etiologic and therapeutic considerations. Diabetes Rev 3:510-564, 1995
5. Jacobson HR, Striker GE for the Workshop Group: Report on a workshop to develop management recommendations for the prevention of progression in chronic renal disease. Am J Kidney Dis 25:103-106, 1995
6. Krolewski AS, Warram JH: Natural history of diabetic nephropathy. Diabetes Rev 3:446-459, 1995
7. Mogensen CE, Keane WF, Bennett PH, Jerums G, Parving H-H, Passa P, Steffes MW, Striker GE, Viberti GC: Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet 346:1080-1084, 1995